Immunomodulatory effect of cimetidine on the proliferative responses of splenocytes from T. cruzi-infected rats

Rev Inst Med Trop Sao Paulo. 1991 May-Jun;33(3):187-92. doi: 10.1590/s0036-46651991000300004.

Abstract

The immunomodulatory effect of cimetidine (CIM), a histamine type-2 receptor antagonist, was evaluated in respect to the blastogenic response to Con A of Wistar Furth (WF) rats infected by the Y strain of Trypanosoma cruzi (T. cruzi). Enhancement of blastogenesis of normal splenocytes was observed at a concentration of 10(3) M. However, the splenocytes from infected animals responded to concentrations of CIM ranging from 10(-8) to 10(-3) M. The mitogenic response to Con A of cells from infected animals was restored in the presence of CIM. The results show that CIM modulates the "in vitro" proliferative response of cells from T. cruzi-infected rats and suggest an immunoregulatory role of histamine and/or of cells that express H2 receptors in this infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Chagas Disease / immunology*
  • Cimetidine / pharmacology*
  • Concanavalin A / pharmacology
  • Female
  • Lymphocyte Activation / drug effects*
  • Male
  • Rats
  • Rats, Inbred WF
  • Receptors, Histamine H2 / drug effects
  • Receptors, Histamine H2 / immunology
  • Spleen / immunology
  • T-Lymphocytes, Regulatory / drug effects*
  • T-Lymphocytes, Regulatory / immunology

Substances

  • Receptors, Histamine H2
  • Concanavalin A
  • Cimetidine